Skip to main content


February 16, 2021
Trial to provide first clinical experience in fistula surveillance for early detection and prediction of fistula stenosis
February 10, 2021
Ruptured abdominal aortic aneurysms (rAAA) are responsible for nearly 2% of all deaths in U.S. men over the age of 65. Endovascular aneurysm repair (EVAR) has emerged as a newer and less invasive alternative to open repair for rAAA, and current…
February 05, 2021
One-year results from BIOLUX AV published and presented at LINC 2021 on use of DCB angioplasty for hemodialysis access.
February 03, 2021
BATON ROUGE- Cardiovascular Institute of the South (CIS) electrophysiologist, Dr. Robert Drennan, is the first in Baton Rouge, and second in the state, to implant the Gallant™ Implantable Cardioverter-Defibrillator (ICD), the first-of-its-kind with…
February 03, 2021
Transit Scientific today announced the close of its Series A financing round. The round was led by a large multinational investor and joined by previous seed investors. Transit Scientific achieved FDA clearances and multi-center, multi-user, safe-…
February 02, 2021
BATON ROUGE- Cardiovascular Institute of the South (CIS) interventional cardiologist, Dr. Niksad Abraham, is the first at Baton Rouge General to use the CardioMEMS™ HF System to treat heart failure.
February 02, 2021
Fluidx Medical Technology announced GPX Embolic Device first patient use cases were presented at the Leipzig Interventional Course (LINC) in Leipzig, Germany.
February 02, 2021
Lifelike tool enables neurointerventionalists to simulate fluoroscopy-guided procedures and validate success removing blockages from different artery access points in a variety of anatomies.
January 27, 2021
Trio of studies demonstrate that FLEX Vessel Prep System safely and effectively modifies obstructive plaque to facilitate delivery of definitive therapies
January 26, 2021
Two major randomized controlled trials (RCTs) show no difference in mortality between patients treated with the Philips Stellarex drug-coated balloon (DCB) and those treated with percutaneous angioplasty (PTA), the current standard of care.
January 25, 2021
11F mechanical thrombectomy system removes large clots in deep vein thrombosis (DVT) PARK CITY, Utah January 22, 2021.   Control Medical Technology announced the FDA cleared Control 11F Mechanical Thrombectomy system was used to remove large blood…
Back to Top